SCHEMBL17526544

SCHEMBL17526544

CCCC[C@@H](CO)CCCC(=O)OC

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.50
LMNA P02545 2/20 0.50
ALDH1A1 P00352 1/20 0.50
CYP3A4 P08684 1/20 0.50
ATM Q13315 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
MAPT P10636 1/20 0.44
MAPK1 P28482 1/20 0.44
CA2 P00918 4/20 0.43
CA1 P00915 1/20 0.43
CA12 O43570 2/20 0.42
CA14 Q9ULX7 2/20 0.42
KDM4E B2RXH2 1/20 0.41
DUSP3 P51452 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
CA7 P43166 1/20 0.40
CA9 Q16790 1/20 0.40
KDM5A P29375 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17526798 1.00 TSHR (0.50) TSHRLMNAALDH1A1CYP3A4ATM
SCHEMBL17526659 0.93 TSHR (0.50) TSHRLMNAALDH1A1CYP3A4ATM
SCHEMBL15187093 0.93 ALDH1A1 (0.50) TSHRLMNAALDH1A1CYP3A4ATM
SCHEMBL17526723 0.93 TSHR (0.50) TSHRLMNAALDH1A1CYP3A4ATM
SCHEMBL2900623 0.89 LMNA (0.62) TSHRLMNACYP3A4ATMTDP1
SCHEMBL16021262 0.89 LMNA (0.62) TSHRLMNACYP3A4ATMTDP1
SCHEMBL1457039 0.89 LMNA (0.62) TSHRLMNACYP3A4ATMTDP1
SCHEMBL12998128 0.88 LMNA (0.60) TSHRLMNACYP3A4ATMTDP1
SCHEMBL17526409 0.87 LMNA (0.48) TSHRLMNAALDH1A1CYP3A4ATM
SCHEMBL17526393 0.87 LMNA (0.48) TSHRLMNAALDH1A1CYP3A4ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160039879-A1 NOVEL CYCLOSPORIN DERIVATIVES AND USES THEREOF S&T GLOBAL INC. (US) 2016-02-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160039879-A1 NOVEL CYCLOSPORIN DERIVATIVES AND USES THEREOF FKBP1B, MALT1, FKBP5 TSHR 4131/4885LMNA 3497/4885ALDH1A1 2376/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.